These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 9381547)
1. Clinical significance of renal allograft biopsies with "borderline changes," as defined in the Banff Schema. Saad R; Gritsch HA; Shapiro R; Jordan M; Vivas C; Scantlebury V; Demetris AJ; Randhawa PS Transplantation; 1997 Oct; 64(7):992-5. PubMed ID: 9381547 [TBL] [Abstract][Full Text] [Related]
2. Significance of the Banff borderline biopsy. Schweitzer EJ; Drachenberg CB; Anderson L; Papadimetriou JC; Kuo PC; Johnson LB; Klassen DK; Hoehn-Saric E; Weir MR; Bartlett ST Am J Kidney Dis; 1996 Oct; 28(4):585-8. PubMed ID: 8840950 [TBL] [Abstract][Full Text] [Related]
3. A blinded retrospective analysis of renal allograft pathology using the Banff schema: implications for clinical management. Dean DE; Kamath S; Peddi VR; Schroeder TJ; First MR; Cavallo T Transplantation; 1999 Sep; 68(5):642-5. PubMed ID: 10507482 [TBL] [Abstract][Full Text] [Related]
4. Borderline Changes on Dysfunctional Renal Allograft Biopsies: Clinical Relevance in a Living Related Renal Transplant Setting. Mubarak M; Shakeel S; Abbas K; Aziz T; Zafar MN; Naqvi SA; Rizvi SA Exp Clin Transplant; 2017 Feb; 15(Suppl 1):24-27. PubMed ID: 28260426 [TBL] [Abstract][Full Text] [Related]
5. Follow-up of patients with borderline changes in renal allograft biopsies: clinical outcome and evaluation of other histological features in addition to tubulitis. Papadimitriou J; Drachenberg C; Anderson L; Bartlett S; Johnson L; Klassen D; Hoehn-Saric E; Weir M; Schweitzer E Transplant Proc; 1996 Feb; 28(1):517-8. PubMed ID: 8644334 [No Abstract] [Full Text] [Related]
6. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of renal biopsies showing concurrent acute rejection and tacrolimus-associated tubular vacuolization. Randhawa PS; Saad RS; Jordan M; Scantlebury V; Vivas C; Shapiro R Transplantation; 1999 Jan; 67(1):85-9. PubMed ID: 9921801 [TBL] [Abstract][Full Text] [Related]
8. An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome. Bates WD; Davies DR; Welsh K; Gray DW; Fuggle SV; Morris PJ Nephrol Dial Transplant; 1999 Oct; 14(10):2364-9. PubMed ID: 10528659 [TBL] [Abstract][Full Text] [Related]
9. Impact of Banff borderline acute rejection among renal allograft recipients. Matoza JR; Danguilan RA; Chicano S Transplant Proc; 2008 Sep; 40(7):2303-6. PubMed ID: 18790219 [TBL] [Abstract][Full Text] [Related]
10. Protocol biopsies in kidney transplant recipients: histologic findings as prognostic markers for graft function and outcome. Masin-Spasovska J; Spasovski G; Dzikova S; Grcevska L; Petrusevska G; Lekovski Lj; Popov Z; Ivanovski N Transplant Proc; 2005 Mar; 37(2):705-8. PubMed ID: 15848508 [TBL] [Abstract][Full Text] [Related]
11. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. Woodle ES; Cronin D; Newell KA; Millis JM; Bruce DS; Piper JB; Haas M; Josephson MA; Thistlethwaite JR Transplantation; 1996 Oct; 62(7):906-10. PubMed ID: 8878382 [TBL] [Abstract][Full Text] [Related]
12. Borderline rejection after renal transplantation--to treat or not to treat. Beimler J; Zeier M Clin Transplant; 2009 Dec; 23 Suppl 21():19-25. PubMed ID: 19930312 [TBL] [Abstract][Full Text] [Related]
13. Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts. Gough J; Rush D; Jeffery J; Nickerson P; McKenna R; Solez K; Trpkov K Nephrol Dial Transplant; 2002 Jun; 17(6):1081-4. PubMed ID: 12032200 [TBL] [Abstract][Full Text] [Related]
14. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children. Birk PE; Stannard KM; Konrad HB; Blydt-Hansen TD; Ogborn MR; Cheang MS; Gartner JG; Gibson IW Pediatr Transplant; 2004 Feb; 8(1):29-38. PubMed ID: 15009838 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the Banff classification. Waiser J; Schreiber M; Budde K; Böhler T; Kraus W; Hauser I; Riess R; Neumayer HH Transpl Int; 2000; 13 Suppl 1():S106-11. PubMed ID: 11111974 [TBL] [Abstract][Full Text] [Related]
16. Pancreas allograft rejection: analysis of concurrent renal allograft biopsies and posttherapy follow-up biopsies. Troxell ML; Koslin DB; Norman D; Rayhill S; Mittalhenkle A Transplantation; 2010 Jul; 90(1):75-84. PubMed ID: 20548259 [TBL] [Abstract][Full Text] [Related]
17. The utility of 6-month protocol renal biopsy under modern immunosuppression. Yango A; Gohh R; Wang LJ; Morrissey P; Shih M; Lowery K; Charpentier K; Gautam A; Mendonca C; Kumar S; Dworkin L; Monaco A Clin Nephrol; 2008 Dec; 70(6):490-5. PubMed ID: 19049705 [TBL] [Abstract][Full Text] [Related]
18. Borderline changes in the Banff schema: rejection or no rejection? Gaber LW Transplant Proc; 2004 Apr; 36(3):755-7. PubMed ID: 15110652 [TBL] [Abstract][Full Text] [Related]
19. Histological findings in early routine biopsies of stable renal allograft recipients. Rush DN; Henry SF; Jeffery JR; Schroeder TJ; Gough J Transplantation; 1994 Jan; 57(2):208-11. PubMed ID: 8310509 [TBL] [Abstract][Full Text] [Related]
20. Can a diagnosis of renal allograft rejection be based on histology alone? Midtvedt K; Hartmann A; Sund S Clin Transplant; 1998 Aug; 12(4):300-2. PubMed ID: 9686323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]